From The Economic Times · ET Online · · 40s
NATCO Pharma Launches Carboplatin in US Market
NATCO Pharma USA partners with Teyro Labs to launch generic Carboplatin injection in US to address drug shortages.
In brief
NATCO Pharma USA partners with Teyro Labs to launch generic Carboplatin injection in US to address drug shortages. NATCO Pharma USA launched Carboplatin injection in US market with Teyro Labs to address critical drug shortages. Originally reported by The Economic Times.
NATCO Pharma USA Launch
NATCO Pharma USA announced the launch of Carboplatin Injection, a generic version of Paraplatin, in the US market.
Collaboration with Teyro Labs
The US subsidiary partners with Chennai-based Indian pharmaceutical company Teyro Labs Pvt Ltd for manufacturing.
Addressing Drug Shortages
The launch aims to address critical shortages of Carboplatin injection in the US market for advanced ovarian carcinoma treatment.
The headline
NATCO Pharma USA launched Carboplatin injection in US market with Teyro Labs to address critical drug shortages.
